AmbioPharm
North Augusta · Founded 2005
About AmbioPharm
AmbioPharm is a manufacturing company that manufactures active pharmaceutical ingredients and generic peptides. It undertakes development and production of research-grade complex peptide generic pharmaceuticals and active pharmaceutical ingredients for pre-clinical in-vitro, medicinal, and toxicology programs through its responsive business model and rapid manufacturing processes that enable pharmaceutical and biotech companies to take their peptide projects from preclinical and clinical to commercial quickly at lower costs.
Company Facts
- Founded: 2005
- Legal name: AmbioPharm, Inc.
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $50K – $100K
- Total funding: $24.0M
- Funding stage: Private Equity
- Last round: Private Equity (Sep 2018)
- Website: ambiopharm.com
- Phone: (415) 921-3593
Social Profiles
Canonical: https://fsome.com/organization/ambiopharm-8294047 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.